eli lilly sues four telehealth compounding glp-1 companies The lawsuit alleges that Zepbound and Mounjaro manufacturer misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's Wegovy and Ozempic Weight Loss Drugs versus skinny Dose:7.50 mg

eli lilly sues four telehealth compounding glp-1 companies The lawsuit alleges that Zepbound and Mounjaro manufacturer misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's Wegovy and Ozempic Weight Loss Drugs versus skinny Dose:7.50 mg

Weight Loss Drugs versus Bariatric Surgery for Obesity Treatment

Telehealth-Only Clinics ✕ Prescription based on online questionnaire ✕ No baseline or follow-up body composition data ✕ No bloodwork monitoring during treatment ✕ Scale weight as only metric of progress ✕ No protocol for muscle preservation ✕ Limited ability to detect or manage side effects Moonshot Medical Approach ✓ In-person evaluation with comprehensive bloodwork ✓ Baseline and follow-up DEXA body composition scans ✓ Regular metabolic panel monitoring (liver, kidney, thyroid, lipids) ✓ Fat loss vs

skinny

Dose:7.50 mg

Here are the three main reasons: GLP-1s Help With Conditions That Disproportionately Affect Bipolar Disorder “There’s a high percentage of people living with bipolar disorder who also experience metabolic changes in their body that put them at risk for things like heart disease and type 2 diabetes,” says Vijay Gorrepati, MD, psychiatrist at UT Health Austin’s Bipolar Disorder Center in Texas, which is associated with Dell Medical School